226 related articles for article (PubMed ID: 24094605)
1. Ambivalent roles of carboxypeptidase B in the lytic susceptibility of fibrin.
Kovács A; Szabó L; Longstaff C; Tenekedjiev K; Machovich R; Kolev K
Thromb Res; 2014 Jan; 133(1):80-7. PubMed ID: 24094605
[TBL] [Abstract][Full Text] [Related]
2. Complete inhibition of fibrinolysis by sustained carboxypeptidase B activity: the role and requirement of plasmin inhibitors.
Walker JB; Bajzar L
J Thromb Haemost; 2007 Jun; 5(6):1257-64. PubMed ID: 17389009
[TBL] [Abstract][Full Text] [Related]
3. Thrombin-activable fibrinolysis inhibitor attenuates (DD)E-mediated stimulation of plasminogen activation by reducing the affinity of (DD)E for tissue plasminogen activator. A potential mechanism for enhancing the fibrin specificity of tissue plasminogen activator.
Stewart RJ; Fredenburgh JC; Rischke JA; Bajzar L; Weitz JI
J Biol Chem; 2000 Nov; 275(47):36612-20. PubMed ID: 10970891
[TBL] [Abstract][Full Text] [Related]
4. Kinetics of activated thrombin-activatable fibrinolysis inhibitor (TAFIa)-catalyzed cleavage of C-terminal lysine residues of fibrin degradation products and removal of plasminogen-binding sites.
Foley JH; Cook PF; Nesheim ME
J Biol Chem; 2011 Jun; 286(22):19280-6. PubMed ID: 21467042
[TBL] [Abstract][Full Text] [Related]
5. Regulation of fibrinolysis by C-terminal lysines operates through plasminogen and plasmin but not tissue-type plasminogen activator.
Silva MM; Thelwell C; Williams SC; Longstaff C
J Thromb Haemost; 2012 Nov; 10(11):2354-60. PubMed ID: 22974122
[TBL] [Abstract][Full Text] [Related]
6. Generation and characterization of a highly stable form of activated thrombin-activable fibrinolysis inhibitor.
Marx PF; Havik SR; Marquart JA; Bouma BN; Meijers JC
J Biol Chem; 2004 Feb; 279(8):6620-8. PubMed ID: 14660622
[TBL] [Abstract][Full Text] [Related]
7. Activated thrombin-activatable fibrinolysis inhibitor (TAFIa) attenuates fibrin-dependent plasmin generation on thrombin-activated platelets.
Ni R; Neves MAD; Wu C; Cerroni SE; Flick MJ; Ni H; Weitz JI; Gross PL; Kim PY
J Thromb Haemost; 2020 Sep; 18(9):2364-2376. PubMed ID: 32506822
[TBL] [Abstract][Full Text] [Related]
8. A study of the mechanism of inhibition of fibrinolysis by activated thrombin-activable fibrinolysis inhibitor.
Wang W; Boffa MB; Bajzar L; Walker JB; Nesheim ME
J Biol Chem; 1998 Oct; 273(42):27176-81. PubMed ID: 9765237
[TBL] [Abstract][Full Text] [Related]
9. Thrombin-activable fibrinolysis inhibitor zymogen does not play a significant role in the attenuation of fibrinolysis.
Foley JH; Kim P; Nesheim ME
J Biol Chem; 2008 Apr; 283(14):8863-7. PubMed ID: 18252711
[TBL] [Abstract][Full Text] [Related]
10. The intrinsic threshold of the fibrinolytic system is modulated by basic carboxypeptidases, but the magnitude of the antifibrinolytic effect of activated thrombin-activable fibrinolysis inhibitor is masked by its instability.
Walker JB; Bajzar L
J Biol Chem; 2004 Jul; 279(27):27896-904. PubMed ID: 15128744
[TBL] [Abstract][Full Text] [Related]
11. Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration-dependent manner. Study of seven plasminogen activators in an internal clot lysis model.
Guimarães AH; Rijken DC
Thromb Haemost; 2004 Mar; 91(3):473-9. PubMed ID: 14983222
[TBL] [Abstract][Full Text] [Related]
12. Lytic resistance of fibrin containing red blood cells.
Wohner N; Sótonyi P; Machovich R; Szabó L; Tenekedjiev K; Silva MM; Longstaff C; Kolev K
Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2306-13. PubMed ID: 21737785
[TBL] [Abstract][Full Text] [Related]
13. Activated thrombin-activatable fibrinolysis inhibitor reduces the ability of high molecular weight fibrin degradation products to protect plasmin from antiplasmin.
Schneider M; Brufatto N; Neill E; Nesheim M
J Biol Chem; 2004 Apr; 279(14):13340-5. PubMed ID: 14715654
[TBL] [Abstract][Full Text] [Related]
14. The interplay between tissue plasminogen activator domains and fibrin structures in the regulation of fibrinolysis: kinetic and microscopic studies.
Longstaff C; Thelwell C; Williams SC; Silva MM; Szabó L; Kolev K
Blood; 2011 Jan; 117(2):661-8. PubMed ID: 20966169
[TBL] [Abstract][Full Text] [Related]
15. The kinetics of plasminogen activation by thrombin-cleaved pro-urokinase and promotion of its activity by fibrin fragment E-2 and by tissue plasminogen activator.
Liu JN; Gurewich V
Blood; 1993 Feb; 81(4):980-7. PubMed ID: 8428004
[TBL] [Abstract][Full Text] [Related]
16. A study of the protection of plasmin from antiplasmin inhibition within an intact fibrin clot during the course of clot lysis.
Schneider M; Nesheim M
J Biol Chem; 2004 Apr; 279(14):13333-9. PubMed ID: 14715655
[TBL] [Abstract][Full Text] [Related]
17. Modulation of fibrin cofactor activity in plasminogen activation.
Nesheim M; Walker J; Wang W; Boffa M; Horrevoets A; Bajzar L
Ann N Y Acad Sci; 2001; 936():247-60. PubMed ID: 11460482
[TBL] [Abstract][Full Text] [Related]
18. Zinc delays clot lysis by attenuating plasminogen activation and plasmin-mediated fibrin degradation.
Henderson SJ; Stafford AR; Leslie BA; Kim PY; Vaezzadeh N; Ni R; Fredenburgh JC; Weitz JI
Thromb Haemost; 2015 Jun; 113(6):1278-88. PubMed ID: 25789495
[TBL] [Abstract][Full Text] [Related]
19. Fibrin structures during tissue-type plasminogen activator-mediated fibrinolysis studied by laser light scattering: relation to fibrin enhancement of plasminogen activation.
Bauer R; Hansen SL; Jones G; Suenson E; Thorsen S; Ogendal L
Eur Biophys J; 1994; 23(4):239-52. PubMed ID: 7805626
[TBL] [Abstract][Full Text] [Related]
20. [Regulatory mechanism of fibrinolysis system by thrombin activatable fibrinolysis inhibitor (TAFI)].
Urano T
Nihon Yakurigaku Zasshi; 2000 Nov; 116(5):298-303. PubMed ID: 11215380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
